156 related articles for article (PubMed ID: 24259375)
1. Cisplatin inhibits bone healing during distraction osteogenesis.
Stine KC; Wahl EC; Liu L; Skinner RA; Vanderschilden J; Bunn RC; Montgomery CO; Suva LJ; Aronson J; Becton DL; Nicholas RW; Swearingen CJ; Lumpkin CK
J Orthop Res; 2014 Mar; 32(3):464-70. PubMed ID: 24259375
[TBL] [Abstract][Full Text] [Related]
2. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity.
Stine KC; Wahl EC; Liu L; Skinner RA; VanderSchilden J; Bunn RC; Montgomery CO; Aronson J; Becton DL; Nicholas RW; Swearingen CJ; Suva LJ; Lumpkin CK
J Orthop Res; 2016 Oct; 34(10):1716-1724. PubMed ID: 26867804
[TBL] [Abstract][Full Text] [Related]
3. Distraction osteogenesis in TNF receptor 1 deficient mice is protected from chronic ethanol exposure.
Wahl EC; Aronson J; Liu L; Skinner RA; Ronis MJ; Lumpkin CK
Alcohol; 2012 Mar; 46(2):133-8. PubMed ID: 21908154
[TBL] [Abstract][Full Text] [Related]
4. Direct bone formation during distraction osteogenesis does not require TNFalpha receptors and elevated serum TNFalpha fails to inhibit bone formation in TNFR1 deficient mice.
Wahl EC; Aronson J; Liu L; Skinner RA; Miller MJ; Cockrell GE; Fowlkes JL; Thrailkill KM; Bunn RC; Ronis MJ; Lumpkin CK
Bone; 2010 Feb; 46(2):410-7. PubMed ID: 19772956
[TBL] [Abstract][Full Text] [Related]
5. Chronic ethanol exposure inhibits distraction osteogenesis in a mouse model: role of the TNF signaling axis.
Wahl EC; Aronson J; Liu L; Liu Z; Perrien DS; Skinner RA; Badger TM; Ronis MJ; Lumpkin CK
Toxicol Appl Pharmacol; 2007 May; 220(3):302-10. PubMed ID: 17391719
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis.
Perrien DS; Brown EC; Fletcher TW; Irby DJ; Aronson J; Gao GG; Skinner RA; Hogue WR; Feige U; Suva LJ; Ronis MJ; Badger TM; Lumpkin CK
J Pharmacol Exp Ther; 2002 Dec; 303(3):904-8. PubMed ID: 12438508
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
Ferrari S; Ruggieri P; Cefalo G; Tamburini A; Capanna R; Fagioli F; Comandone A; Bertulli R; Bisogno G; Palmerini E; Alberghini M; Parafioriti A; Linari A; Picci P; Bacci G
J Clin Oncol; 2012 Jun; 30(17):2112-8. PubMed ID: 22564997
[TBL] [Abstract][Full Text] [Related]
8. Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis.
Wahl EC; Perrien DS; Aronson J; Liu Z; Fletcher TW; Skinner RA; Feige U; Suva LJ; Badger TM; Lumpkin CK
Alcohol Clin Exp Res; 2005 Aug; 29(8):1466-72. PubMed ID: 16131855
[TBL] [Abstract][Full Text] [Related]
9. Limb Salvage by Distraction Osteogenesis for Distal Tibial Osteosarcoma in a Young Child: A Case Report.
He X; Zhang HL; Hu YC
Orthop Surg; 2016 May; 8(2):253-6. PubMed ID: 27384736
[TBL] [Abstract][Full Text] [Related]
10. Effect of neoadjuvant chemotherapy on distraction osteogenesis in the goat model.
Gravel CA; Le TT; Chapman MW
Clin Orthop Relat Res; 2003 Jul; (412):213-24. PubMed ID: 12838073
[TBL] [Abstract][Full Text] [Related]
11. Bone Regeneration Is Promoted by Orally Administered Bovine Lactoferrin in a Rabbit Tibial Distraction Osteogenesis Model.
Li W; Zhu S; Hu J
Clin Orthop Relat Res; 2015 Jul; 473(7):2383-93. PubMed ID: 25822454
[TBL] [Abstract][Full Text] [Related]
12. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling.
Gerstenfeld LC; Cho TJ; Kon T; Aizawa T; Cruceta J; Graves BD; Einhorn TA
Cells Tissues Organs; 2001; 169(3):285-94. PubMed ID: 11455125
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis.
Moore DC; Ehrlich MG; McAllister SC; Machan JT; Hart CE; Voigt C; Lesieur-Brooks AM; Weber EW
J Bone Joint Surg Am; 2009 Aug; 91(8):1973-84. PubMed ID: 19651957
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin antibody enhances bone formation in a rat model of distraction osteogenesis.
McDonald MM; Morse A; Birke O; Yu NYC; Mikulec K; Peacock L; Schindeler A; Liu M; Ke HZ; Little DG
J Orthop Res; 2018 Apr; 36(4):1106-1113. PubMed ID: 28884841
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.
Zhang B; Ramesh G; Norbury CC; Reeves WB
Kidney Int; 2007 Jul; 72(1):37-44. PubMed ID: 17396112
[TBL] [Abstract][Full Text] [Related]
16. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.
Ramesh G; Reeves WB
Kidney Int; 2004 Feb; 65(2):490-9. PubMed ID: 14717919
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of nicotine on bone regeneration in mandibular distraction osteogenesis.
Ma L; Zheng LW; Cheung LK
Front Biosci; 2007 May; 12():3256-62. PubMed ID: 17485296
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors.
Picci P; Bacci G; Ferrari S; Mercuri M
Ann Oncol; 1997 Nov; 8(11):1107-15. PubMed ID: 9426330
[TBL] [Abstract][Full Text] [Related]
19. A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Bacci G; Ferrari S; Tienghi A; Bertoni F; Mercuri M; Longhi A; Fiorentini G; Forni C; Bacchini P; Rimondini S; De Giorgi U; Picci P
Eur J Surg Oncol; 2001 Feb; 27(1):98-104. PubMed ID: 11237499
[TBL] [Abstract][Full Text] [Related]
20. Bone regeneration and fracture healing. Experience with distraction osteogenesis model.
Richards M; Goulet JA; Weiss JA; Waanders NA; Schaffler MB; Goldstein SA
Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S191-204. PubMed ID: 9917639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
